Current Assets
Work in process
Gilead Sciences Work in process decreased by 2.3% to $1.28B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.6%, from $1.08B to $1.28B. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 6.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2015
Last reportedQ1 2026May 7, 2026
Parent metricInventories
Metric ID:
inv_work_in_progressHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $924M | $727M | $590M | $540M | $484M | $430M | $577M | $570M | $622M | $614M | $847M | $778M | $803M | $684M | $847M | $1.08B | $1.04B | $1.34B | $1.31B | $1.28B |
| QoQ Change | — | -21.3% | -18.8% | -8.5% | -10.4% | -11.2% | +34.2% | -1.2% | +9.1% | -1.3% | +37.9% | -8.1% | +3.2% | -14.8% | +23.8% | +27.0% | -3.4% | +29.1% | -2.6% | -2.3% |
| YoY Change | — | — | — | — | -47.6% | -40.9% | -2.2% | +5.6% | +28.5% | +42.8% | +46.8% | +36.5% | +29.1% | +11.4% | +0.0% | +38.3% | +29.4% | +96.1% | +54.2% | +18.6% |
| % of Inventories | 76.0% | 64.9% | 52.9% | 45.2% | 44.2% | 37.8% | 43.9% | 39.7% | 40.2% | 39.9% | 53.7% | 51.5% | 59.0% | 43.7% | 45.1% | 53.3% | 49.8% | 51.5% | 50.3% | 52.6% |
| Share Change | — | -11.1pp | -12.0pp | -7.6pp | -1.0pp | -6.5pp | +6.2pp | -4.2pp | +0.5pp | -0.3pp | +13.8pp | -2.2pp | +7.4pp | -15.3pp | +1.4pp | +8.2pp | -3.5pp | +1.8pp | -1.2pp | +2.3pp |
Range$430M – $1.34B
CAGR+7.0%
Avg YoY Growth+21.7%
Median YoY Growth+28.8%
Current Streak2 quarters decline
Work in process at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's work in process?
- Gilead Sciences (GILD) reported work in process of $1.28B in Q1 2026.
- How has Gilead Sciences's work in process changed year-over-year?
- Gilead Sciences's work in process increased by 18.6% year-over-year, from $1.08B to $1.28B.
- What is the long-term trend for Gilead Sciences's work in process?
- Over 5 years (2020 to 2025), Gilead Sciences's work in process has grown at a 6.0% compound annual growth rate (CAGR), from $976M to $1.31B.